Footnotes

• X @Research4Babies

• Deceased 2024

• Contributors TP is the guarantor. TP: Writing—review and editing, Writing—original draft, Visualisation, Project administration, Methodology, Investigation, Formal analysis, Conceptualisation. Guarantor. LKC: Writing –review and editing, Validation, Investigation, Supervision. BS: Writing—review and editing, Validation, Investigation. BU: Writing—review and editing, Validation, Investigation. CHW: Writing—review and editing, Validation, Investigation. NB: Writing—review and editing, Validation, Investigation. KG: Writing—review and editing, Validation, Investigation. MH: Writing—review and editing, Validation, Investigation. EMD: Writing—review and editing, Validation, Investigation, Funding acquisition. LS: Writing—review and editing, Validation, Investigation. GL: Writing—review and editing, Validation, Investigation. TS: Writing—review and editing, Validation, Investigation. HF: Writing—review and editing, Validation, Investigation. LK: Writing—review and editing, Validation, Investigation. JBua: Writing—review and editing, Validation, Investigation. AA: Writing—review and editing, Validation, Methodology, Formal analysis, Data curation. BHYL: Writing—review and editing, Validation, Investigation. JBuc: Writing—review and editing, Validation, Investigation. UK-K: Writing—review and editing, Validation, Investigation. CES: Writing—review and editing, Validation, Investigation. KG: Writing—review and editing, Validation, Investigation. IS: Writing—review and editing, Validation, Investigation. KK-S: Writing—review and editing, Validation, Investigation. GMS: Writing—review and editing, Visualisation, Validation, Supervision, Project administration, Methodology, Investigation, Funding acquisition, Conceptualisation. GP: Writing—review and editing, Visualisation, Validation, Supervision, Project administration, Methodology, Investigation, Funding acquisition, Formal analysis, Conceptualisation. COSGOD III study group: Investigation.

• Funding The COSGOD III trial was funded by the Austrian Science Fund (Fonds zur Förderung der wissenschaftlichen Forschung (FWF) Austria) through an unconditional and unrestricted grant (KLI 586-B31). The COSGOD III trial received support from the Austrian Science Fund and the Health Research Board (HRB), Clinical Research Facility at the University of Cork for the submitted work and from the Stollery Children’s Hospital Foundation facilitated by the Women and Children’s Health Research Institute; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. Health Research Board (HRB) Clinical Research Facility at University College Cork supported the study at the Infant Centre, University College Cork, Cork University Maternity Hospital, Cork, Ireland. GMS was a recipient of the Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation, a National New Investigator of the Heart and Stroke Foundation Canada and an Alberta New Investigator of the Heart and Stroke Foundation Alberta. This research was facilitated by the Women and Children’s Health Research Institute through the support of the Stollery Children’s Hospital Foundation. No funding was received for the analysis of the data presented in the submitted manuscript, and funders had no influence on analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.

• Competing interests None declared.

• Provenance and peer review Not commissioned; externally peer reviewed.

• Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.